BMPR2 and pulmonary arterial hypertension: The observation that etanercept treatment in preclinical PAH normalized BMPR-II levels, restored normal NOTCH expression levels and reversed the progression of PAH provides a justification to explore the clinical use of anti-TNFα approaches in PAH patients.